The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Coleman Mark since 2019.
This trader's CIK number is 1658379.
At the time of last reporting, Coleman Mark was the Officer of Axsome Therapeutics, Inc.. (stock ticker symbol AXSM).
Also see all insider trading activities at Axsome Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | AXSM | 0 | $0 | 10,500 | $1,105,847 | 0 | $0 |
| 2024 | AXSM | 0 | $0 | 10,497 | $789,111 | 33,410 | $198,455 |
| 2023 | AXSM | 0 | $0 | 29,588 | $2,224,455 | 11,016 | $40,428 |
| 2022 | AXSM | 0 | $0 | 0 | $0 | 3,496 | $4,544 |
| 2021 | AXSM | 1,930 | $79,246 | 0 | $0 | 0 | $0 |
| 2020 | AXSM | 650 | $51,025 | 0 | $0 | 0 | $0 |
| 2019 | AXSM | 25,950 | $536,094 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-28 | AXSM | Sale | 3,750 | 103.43 | 387,862 |
| 2025-05-27 | AXSM | Sale | 3,750 | 105.47 | 395,512 |
| 2025-05-20 | AXSM | Sale | 3,000 | 107.49 | 322,473 |
| 2024-11-19 | AXSM | Option Ex | 33,410 | 5.94 | 198,455 |
| 2024-05-28 | AXSM | Sale | 5,249 | 75.21 | 394,777 |
| 2024-05-29 | AXSM | Sale | 5,248 | 75.14 | 394,334 |
| 2023-09-15 | AXSM | Option Ex | 11,016 | 3.67 | 40,428 |
| 2023-09-15 | AXSM | Sale | 29,588 | 75.18 | 2,224,455 |
| 2022-03-15 | AXSM | Option Ex | 3,496 | 1.30 | 4,544 |
| 2021-11-18 | AXSM | Buy | 1,430 | 35.09 | 50,171 |
| 2021-05-12 | AXSM | Buy | 500 | 58.15 | 29,075 |
| 2020-06-29 | AXSM | Buy | 650 | 78.50 | 51,025 |
| 2019-06-25 | AXSM | Buy | 400 | 23.25 | 9,300 |
| 2019-06-26 | AXSM | Buy | 15,800 | 23.10 | 364,980 |
| 2019-05-13 | AXSM | Buy | 4,650 | 21.44 | 99,696 |
| 2019-03-19 | AXSM | Buy | 5,100 | 12.18 | 62,118 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Coleman Mark (Officer of Axsome Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.